Evidence map›Paper›PMID 27352120›Full record

ArticleClinical transplantation2016

Differential gene expression pattern in biopsies with renal allograft pyelonephritis and allograft rejection.

Steve Oghumu, Uday Nori, Anna Bracewell, Jianying Zhang, Cherri Bott, Gyongyi M Nadasdy, Sergey V Brodsky, Ronald Pelletier, Abhay R Satoskar, Tibor Nadasdy and 1 more

Open access · greenAbstract read
In one paragraph

Article in Clinical transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Steve OghumuDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Uday NoriNephrology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Anna BracewellNephrology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Jianying ZhangDepartment of Biostatistics, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Cherri BottDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Gyongyi M NadasdyDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Sergey V BrodskyDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Ronald PelletierDepartment of Surgery, Comprehensive Transplant Center, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Abhay R SatoskarDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Tibor NadasdyDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, USA. tibor.nadasdy@osumc.edu.
Anjali A SatoskarDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, USA. anjali.satoskar@osumc.edu.
The Ohio State University Wexner Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

Differentiating acute pyelonephritis (APN) from acute rejection (AR) in renal allograft biopsies can sometimes be difficult because of overlapping clinical and histologic features, lack of positive urine cultures,and variable response to antibiotics. We wanted to study differential gene expression between AR and APN using biopsy tissue. Thirty-three biopsies were analyzed using NanoString multiplex platform and PCR (6 transplant baseline biopsies, 8 AR, 15 APN [8 culture positive, 7 culture negative], and 4 native pyelonephritis [NP]). Additional 22 biopsies were tested by PCR to validate the results. CXCL9, CXCL10, CXCL11, and IDO1 were the top differentially expressed genes, upregulated in AR. Lactoferrin (LTF) and CXCL1 were higher in APN and NP. No statistically significant difference in transcript levels was seen between culture-positive and culture-negative APN biopsies. Comparing the overall mRNA signature using Ingenuity pathway analysis, interferon-gamma emerged as the dominant upstream regulator in AR and allograft APN, but not in NP (which clustered separately). Our study suggests that chemokine pathways in graft APN may differ from NP and in fact resemble AR, due to a component of alloreactivity, resulting in variable response to antibiotic treatment. Therefore, cautious addition of steroids might help in resistant cases of graft APN.

Indexed as

Gene Expression RegulationAdultAgedAllograftsBiopsyChemokines, CXCFemaleFollow-Up StudiesGraft RejectionHumansKidneyKidney TransplantationMaleMiddle AgedPolymerase Chain ReactionPyelonephritisChemokines, CXCRNAacute pyelonephritisacute rejectionCXCL1CXCL10CXCL11renal allograft

Identifiers

PMID27352120
PMCPMC5256948
OpenAlexW2460821649

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.